Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Designed for steady fat reduction and long-term success, this program typically results in an average weight loss of 1828 pounds over the course of treatment
Phase 2 Trial Results (NEJM 2023) The landmark Phase 2 trial enrolled 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27) but without diabetes
(4) In addition, in phase 2 trials where it was combined with semaglutide, it lead to significantly more weight loss
"They've often cost consumers more than $1,000 per month and some a lot more than that
CR reduces cancer onset and progression in several models 21
Given that, though the risk of low blood sugar is not higher in older adults, the risk of complications is greater unless those patients commit to carefully monitoring blood sugar levels
